Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in...
Saved in:
| Main Authors: | Elcin Suren, Ersan Cetinkaya, Mustafa Kalayci, Sariye Elif Özyazıcı Özkan, Mehmet Fatih Kucuk, Muhammet Kazim Erol |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Ophthalmological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2020/8861435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optic Coherence Tomography Angiography Findings of Bilateral Choroidal Neovascularization Associated with Optic Disc Drusen Treated with Intravitreal Aflibercept Injection
by: Melih Akıdan, et al.
Published: (2020-01-01) -
Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-01-01) -
Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain.
by: Shumpei Obata, et al.
Published: (2021-01-01) -
Delayed-onset Moraxella nonliquefaciens endophthalmitis following intravitreal injection
by: Paul S. Micevych, et al.
Published: (2025-09-01) -
Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
by: Rebecca Kim, et al.
Published: (2014-01-01)